Advertisement

Virologica Sinica

, Volume 34, Issue 3, pp 315–323 | Cite as

Inhibition of Herpes Simplex Virus-1 Replication by Natural Compound Honokiol

  • Shuai Liu
  • Long Li
  • Lingbing Tan
  • Xiaozhen LiangEmail author
RESEARCH ARTICLE

Abstract

Honokiol is a pleiotropic natural compound isolated from Magnolia and has multiple biological and clinically relevant effects, including anticancer and antimicrobial function. However, the antiviral activity of honokiol has not yet been well studied. Here we showed that honokiol had no effect on herpes simplex virus-1 (HSV-1) entry, but inhibited HSV-1 viral DNA replication, gene expression and the production of new progeny viruses. The combination of honokiol and clinical drug acyclovir augmented inhibition of HSV-1 infection. Our results illustrate that honokiol could be a potential new candidate for clinical consideration in the treatment of HSV-1 infection alone or combination with other therapeutics.

Keywords

Honokiol Herpes simplex virus-1 (HSV-1) Viral replication Anti-viral activity Acyclovir 

Notes

Acknowledgements

We thank Dr. Chunfu Zheng (Fujian Medical University) for providing the HSV-1-GFP virus. This work was supported by the grant from National Key Research and Development Program (2016YFA0502100).

Author Contributions

XL conceived and designed the experiments. SL, LL and LT performed the experiments and analyzed the data. XL wrote and finalized the manuscript. All authors read and approved the final manuscript.

Compliance with Ethical Standards

Conflicts of interest

The authors declare that they have no conflict of interest.

Animal and Human Rights Statement

All animal studies were conducted following protocols approved by the Institutional Animal Care and Usage Committee of Institut Pasteur of Shanghai, Chinese Academy of Sciences.

References

  1. Amblard F, Delinsky D, Arbiser JL, Schinazi RF (2006) Facile purification of honokiol and its antiviral and cytotoxic properties. J Med Chem 49:3426–3427CrossRefGoogle Scholar
  2. Andrei G, Topalis D, Fiten P, McGuigan C, Balzarini J, Opdenakker G, Snoeck R (2012) In vitro-selected drug-resistant varicella-zoster virus mutants in the thymidine kinase and DNA polymerase genes yield novel phenotype-genotype associations and highlight differences between antiherpesvirus drugs. J Virol 86:2641–2652CrossRefGoogle Scholar
  3. Averett C, Bhardwaj A, Arora S, Srivastava SK, Khan MA, Ahmad A, Singh S, Carter JE, Khushman M, Singh AP (2016) Honokiol suppresses pancreatic tumor growth, metastasis and desmoplasia by interfering with tumor-stromal cross-talk. Carcinogenesis 37:1052–1061CrossRefGoogle Scholar
  4. Bai X, Cerimele F, Ushio-Fukai M, Waqas M, Campbell PM, Govindarajan B, Der CJ, Battle T, Frank DA, Ye K, Murad E, Dubiel W, Soff G, Arbiser JL (2003) Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J Biol Chem 278:35501–35507CrossRefGoogle Scholar
  5. Balfour HH Jr, Benson C, Braun J, Cassens B, Erice A, Friedman-Kien A, Klein T, Polsky B, Safrin S (1994) Management of acyclovir-resistant herpes simplex and varicella-zoster virus infections. J Acquir Immune Defic Syndr 7:254–260Google Scholar
  6. Bang KH, Kim YK, Min BS, Na MK, Rhee YH, Lee JP, Bae KH (2000) Antifungal activity of magnolol and honokiol. Arch Pharm Res 23:46–49CrossRefGoogle Scholar
  7. Darling AJ, Boose JA, Spaltro J (1998) Virus assay methods: accuracy and validation. Biologicals 26:105–110CrossRefGoogle Scholar
  8. Elion GB (1993) Acyclovir: discovery, mechanism of action, and selectivity. J Med Virol Suppl 1:2–6CrossRefGoogle Scholar
  9. Elion GB, Furman PA, Fyfe JA, de Miranda P, Beauchamp L, Schaeffer HJ (1977) Selectivity of action of an antiherpetic agent, 9-(2-hydroxyethoxymethyl) guanine. Proc Natl Acad Sci U S A 74:5716–5720CrossRefGoogle Scholar
  10. Fang CY, Chen SJ, Wu HN, Ping YH, Lin CY, Shiuan D, Chen CL, Lee YR, Huang KJ (2015) Honokiol, a lignan biphenol derived from the magnolia tree, inhibits dengue virus type 2 infection. Viruses 7:4894–4910CrossRefGoogle Scholar
  11. Field HJ, Vere Hodge RA (2013) Recent developments in anti-herpesvirus drugs. Br Med Bull 106:213–249CrossRefGoogle Scholar
  12. Fried LE, Arbiser JL (2009) Honokiol, a multifunctional antiangiogenic and antitumor agent. Antioxid Redox Signal 11:1139–1148CrossRefGoogle Scholar
  13. Hafidh RR, Abdulamir AS, Abu Bakar F, Sekawi Z, Jahansheri F, Jalilian FA (2015) Novel antiviral activity of mung bean sprouts against respiratory syncytial virus and herpes simplex virus -1: an in vitro study on virally infected Vero and MRC-5 cell lines. BMC Complement Altern Med 15:179CrossRefGoogle Scholar
  14. Jacobo-Salcedo Mdel R, Gonzalez-Espindola LA, Alonso-Castro AJ, Gonzalez-Martinez Mdel R, Dominguez F, Garcia-Carranca A (2011) Antimicrobial activity and cytotoxic effects of Magnolia dealbata and its active compounds. Nat Prod Commun 6:1121–1124Google Scholar
  15. Jin J, Guo N, Zhang J, Ding Y, Tang X, Liang J, Li L, Deng X, Yu L (2010) The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans. Lett Appl Microbiol 51:351–357CrossRefGoogle Scholar
  16. Kumar A, Kumar Singh U, Chaudhary A (2013) Honokiol analogs: a novel class of anticancer agents targeting cell signaling pathways and other bioactivities. Future Med Chem 5:809–829CrossRefGoogle Scholar
  17. Kuribara H, Stavinoha WB, Maruyama Y (1999) Honokiol, a putative anxiolytic agent extracted from magnolia bark, has no diazepam-like side-effects in mice. J Pharm Pharmacol 51:97–103Google Scholar
  18. Kuribara H, Kishi E, Hattori N, Okada M, Maruyama Y (2000) The anxiolytic effect of two oriental herbal drugs in Japan attributed to honokiol from magnolia bark. J Pharm Pharmacol 52:1425–1429CrossRefGoogle Scholar
  19. Lan KH, Wang YW, Lee WP, Lan KL, Tseng SH, Hung LR, Yen SH, Lin HC, Lee SD (2012) Multiple effects of Honokiol on the life cycle of hepatitis C virus. Liver Int 32:989–997CrossRefGoogle Scholar
  20. Leary JJ, Wittrock R, Sarisky RT, Weinberg A, Levin MJ (2002) Susceptibilities of herpes simplex viruses to penciclovir and acyclovir in eight cell lines. Antimicrob Agents Chemother 46:762–768CrossRefGoogle Scholar
  21. Li Y, Wang S, Zhu H, Zheng C (2011) Cloning of the herpes simplex virus type 1 genome as a novel luciferase-tagged infectious bacterial artificial chromosome. Arch Virol 156:2267–2272CrossRefGoogle Scholar
  22. Li WL, Zhao XC, Zhao ZW, Huang YJ, Zhu XZ, Meng RZ, Shi C, Yu L, Guo N (2016) In vitro antimicrobial activity of honokiol against Staphylococcus aureus in biofilm mode. J Asian Nat Prod Res 18:1178–1185CrossRefGoogle Scholar
  23. Liou KT, Shen YC, Chen CF, Tsao CM, Tsai SK (2003) The anti-inflammatory effect of honokiol on neutrophils: mechanisms in the inhibition of reactive oxygen species production. Eur J Pharmacol 475:19–27CrossRefGoogle Scholar
  24. Maruyama Y, Kuribara H, Morita M, Yuzurihara M, Weintraub ST (1998) Identification of magnolol and honokiol as anxiolytic agents in extracts of saiboku-to, an oriental herbal medicine. J Nat Prod 61:135–138CrossRefGoogle Scholar
  25. Pan J, Zhang Q, Liu Q, Komas SM, Kalyanaraman B, Lubet RA, Wang Y, You M (2014) Honokiol inhibits lung tumorigenesis through inhibition of mitochondrial function. Cancer Prev Res (Phila) 7:1149–1159CrossRefGoogle Scholar
  26. Park J, Lee J, Jung E, Park Y, Kim K, Park B, Jung K, Park E, Kim J, Park D (2004) In vitro antibacterial and anti-inflammatory effects of honokiol and magnolol against Propionibacterium sp. Eur J Pharmacol 496:189–195CrossRefGoogle Scholar
  27. Reusser P (1996) Herpesvirus resistance to antiviral drugs: a review of the mechanisms, clinical importance and therapeutic options. J Hosp Infect 33:235–248CrossRefGoogle Scholar
  28. Sakaue Y, Domon H, Oda M, Takenaka S, Kubo M, Fukuyama Y, Okiji T, Terao Y (2016) Anti-biofilm and bactericidal effects of magnolia bark-derived magnolol and honokiol on Streptococcus mutans. Microbiol Immunol 60:10–16CrossRefGoogle Scholar
  29. Sato Y, Kato A, Maruzuru Y, Oyama M, Kozuka-Hata H, Arii J, Kawaguchi Y (2016) Cellular transcriptional coactivator RanBP10 and herpes simplex virus 1 ICP0 interact and synergistically promote viral gene expression and replication. J Virol 90:3173–3186CrossRefGoogle Scholar
  30. Shigemura K, Arbiser JL, Sun SY, Zayzafoon M, Johnstone PA, Fujisawa M, Gotoh A, Weksler B, Zhau HE, Chung LW (2007) Honokiol, a natural plant product, inhibits the bone metastatic growth of human prostate cancer cells. Cancer 109:1279–1289CrossRefGoogle Scholar
  31. Song JM, Anandharaj A, Upadhyaya P, Kirtane AR, Kim JH, Hong KH, Panyam J, Kassie F (2016) Honokiol suppresses lung tumorigenesis by targeting EGFR and its downstream effectors. Oncotarget 7:57752–57769Google Scholar
  32. Tan EL, Ooi EE, Lin CY, Tan HC, Ling AE, Lim B, Stanton LW (2004) Inhibition of SARS coronavirus infection in vitro with clinically approved antiviral drugs. Emerg Infect Dis 10:581–586CrossRefGoogle Scholar
  33. Tan L, Zhang C, Dematos J, Kuang L, Jung JU, Liang X (2016) CD95 signaling inhibits B cell receptor-mediated gammaherpesviral replication in apoptosis-resistant B lymphoma cells. J Virol 90:9782–9796CrossRefGoogle Scholar
  34. Tian W, Xu D, Deng YC (2012) Honokiol, a multifunctional tumor cell death inducer. Pharmazie 67:811–816Google Scholar
  35. Wolf I, O’Kelly J, Wakimoto N, Nguyen A, Amblard F, Karlan BY, Arbiser JL, Koeffler HP (2007) Honokiol, a natural biphenyl, inhibits in vitro and in vivo growth of breast cancer through induction of apoptosis and cell cycle arrest. Int J Oncol 30:1529–1537Google Scholar
  36. Woodbury A, Yu SP, Wei L, Garcia P (2013) Neuro-modulating effects of honokiol: a review. Front Neurol 4:130CrossRefGoogle Scholar
  37. Wutzler P (1997) Antiviral therapy of herpes simplex and varicella-zoster virus infections. Intervirology 40:343–356CrossRefGoogle Scholar
  38. Xu HL, Tang W, Du GH, Kokudo N (2011) Targeting apoptosis pathways in cancer with magnolol and honokiol, bioactive constituents of the bark of Magnolia officinalis. Drug Discov Ther 5:202–210CrossRefGoogle Scholar
  39. Zhang Q, Zhao W, Ye C, Zhuang J, Chang C, Li Y, Huang X, Shen L, Li Y, Cui Y, Song J, Shen B, Eliaz I, Huang R, Ying H, Guo H, Yan J (2015) Honokiol inhibits bladder tumor growth by suppressing EZH2/miR-143 axis. Oncotarget 6:37335–37348Google Scholar

Copyright information

© Wuhan Institute of Virology, CAS 2019

Authors and Affiliations

  • Shuai Liu
    • 1
    • 2
  • Long Li
    • 1
    • 2
  • Lingbing Tan
    • 1
    • 2
  • Xiaozhen Liang
    • 2
    Email author
  1. 1.University of Chinese Academy of Sciences, Chinese Academy of SciencesBeijingChina
  2. 2.Key Laboratory of Molecular Virology & ImmunologyInstitut Pasteur of ShanghaiShanghaiChina

Personalised recommendations